Avantages
Compensation is above average, Bonus is based on national average not on goal attainment so there is the potential for earning big bonuses during a down year. The company has some potential block busters in their pipeline. Career Ladder II and III promotions are fairly plentiful. The company offers stock options to the top 10% of the sales force.
Inconvénients
Nexium is about to go generic and there is another large layoff looming on the horizon. The sales force is populated with disgruntled tenured reps who remember when budgets were unlimited and new reps eager to work for big pharma. Certain areas of the country have poor work environments while others are supportive. There is a lot of pressure to perform but little guidance on how to achieve that goal since leadership is out of touch with the field. Leadership understand the problems but there is no consensus on a solution. There are many different things being tried but it can appear to be very unorganized.